Further, a comparison between sublingual and intramuscular influenza vaccine application found that sublingual routes elicited systemic immunity similar to that from intramuscular routes, but only the sublingual application leads to a protective Th17 with mucosal IgA protection116. This evidence concerns the gene CD79A and influenza.